A treatment that has been demonstrated to reduce brain damage after stroke is tissue plasminogen activator (t-PA), an enzyme which converts plasminogen to plasmin that dissolves emboli and thrombi [5], thereby restoring CBF. Here, PLG is linked to stroke disorder.